|
The fact that BSV is one of the very few Indian companies
expected to obtain
UK-MCA (expected by March 2004) approved plant for the manufacture
of injectables speaks of the Company's strengths in the formulation
development, project implementation and in attracting and
tying up with leading pharmaceutical companies of the world
for distribution in the regulated markets.
BSV has a formidable product pipeline in various stages of
development. Since the Company has quite a few potential blockbuster
products in its portfolio, it is now looking for alliances
with potential partners with proven strengths in the marketing
and distribution of similar products. BSV firmly believes
that by following the model business alliances and strategic
partnerships, it can significantly reduce the time required
to commercialize these products globally.
|